Protease inhibitor system in horses: classification and detection of a new allele.

This genetic study in horses developed a way to separate previously undifferentiated prealbumins in equine plasma via polyacrylamide gel electrophoresis. The process allowed the identification of a new allele, taking the total prealbumin alleles in Thoroughbred horses to eight. The researchers recommend renaming prealbumins as protease inhibitors due to their function, though they are unsure if this includes other inhibiting proteins.

Introduction to the Research

• This study focuses on a genetic analysis of the protease inhibitor system in horses.
• Protease inhibitors are proteins that help control the activities of proteases, enzymes that break down proteins and peptides. They’re essential in preventing uncontrolled protein degradation within an organism.
• The objective was to classify and detect a new allele within this system using a particular method involving gel electrophoresis.

Methodology and New Allele Identification

• The team developed a method of separation using horizontal thin layer polyacrylamide gel electrophoresis at acid pH. This process allows for the separation of proteins based on their size and charge.
• By using this method, they were able to differentiate the S allele, which was previously thought to be a single entity, into two distinct alleles: S1 and S2.
• This finding increases the total number of known prealbumin alleles in Thoroughbred horses from seven to eight.

Gene Frequencies and Protease Inhibitor Activity

• Alongside the identification of the new allele, the study also presents the gene frequencies of these eight alleles within the Australian Thoroughbred population.
• All eight of these prealbumin types were found to exhibit antiprotease activity – they inhibit protease enzymes from breaking down proteins, thus playing a protective role within the organism.

Recommended Terminology Change

• Due to the discovered anti-protease activity, the researchers suggested that “prealbumin” should be abandoned as a term. Instead, they proposed the term “protease inhibitor”, abbreviated as “Pi”.
• However, it remains unsure whether this new classification will incorporate the known Pi1 and Pi2 described by Junega et al. in 1979.